Thomas W. Griffin
Technik-/Wissenschafts-/F&E-Leiter bei Janssen Oncology, Inc.
Ursprung des Netzwerks ersten Grades von Thomas W. Griffin
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Cougar Biotechnology, Inc. /Old/
 Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA.
17
| Extinct | Pharmaceuticals: Major | 17 |
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA.
10
| Holding Company | Pharmaceuticals: Major | 10 |
Bristol-Myers Squibb Pharmaceutical Research Institute
8
| Subsidiary | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Thomas W. Griffin
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Janus Henderson Investors US LLC
 Janus Henderson Investors US LLC Investment ManagersFinance Janus Henderson Investors US LLC (JHIUS) is a registered investment advisor and mutual fund manager headquartered in Denver, Colorado. The firm was founded in 1969 and formerly known as Janus Capital Management LLC. They are a subsidiary of Janus Henderson US (Holdings) Inc., which is owned by Janus Henderson Group plc (NYSE: JHG, LON: 0RPW) in Great Britain. JHIUS provides investment management services, as an investment adviser or sub-adviser, to pooled investment vehicles. | Investment Managers | Portfolio Manager-Equities | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PALATIN TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| DELCATH SYSTEMS, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| RADIUS HEALTH, INC. | Biotechnology | Director/Board Member | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Corporate Officer/Principal | |
Innovate UK
 Innovate UK Miscellaneous Commercial ServicesCommercial Services Innovate UK promotes, supports and invests in technology research, development, and commercialization. The firm provides access to information about the funding and support opportunities through a range of channels. The company was founded on July 1, 2007 and is headquartered in Swindon, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| KURA ONCOLOGY, INC. | Biotechnology | Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
| Boston University | College/University | Undergraduate Degree | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Graduate Degree | |
| Drexel University | College/University | Undergraduate Degree | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Director/Board Member | |
The Ohio University
 The Ohio University Other Consumer ServicesConsumer Services Central Hockey League operates a professional minor league hockey teams playing in small to medium-sized markets primarily in central and southwestern US states. The league, which was started in 1992, is managed and operated by WPHL, a subsidiary of Global Entertainment Corporation. | College/University | Doctorate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree | |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services University of Miami (Florida) is a private research university with students from around the world that is focused on teaching and learning, the discovery of new knowledge, and service to the South Florida region and beyond. The university was founded in 1925 and it is headquartered in Coral Gables, FL. | College/University | Doctorate Degree | |
| St. Francis College | College/University | Masters Business Admin | |
Pfizer Ltd.
 Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| Pembroke College Cambridge | College/University | Corporate Officer/Principal | |
| PROTAGONIST THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Benevolent Healthcare Foundation
 Benevolent Healthcare Foundation Medical/Nursing ServicesHealth Services Benevolent Healthcare Foundation provides medical supplies and services. The company was founded by James W. Jackson in 1987 and is headquartered in Centennial, CO. | Medical/Nursing Services | Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
Sanofi-Aventis Ltd.
 Sanofi-Aventis Ltd. Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Ltd. provides pharmaceutical services. It focuses on cardiovascular medicine, thrombosis, oncology, metabolic disorders and diseases of the central nervous system. The company was founded in December 2004 and is headquartered in Guildford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| KITE PHARMA INC | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| PUMA BIOTECHNOLOGY, INC. | Pharmaceuticals: Major | General Counsel Director/Board Member Chief Executive Officer Director of Finance/CFO Investor Relations Contact | |
Madison Vaccines, Inc.
 Madison Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Madison Vaccines, Inc. develops vaccines for patients with prostate cancer. It is also developing a sensitivity test to identify those patients who will derive clinical benefit from these vaccines. The firm develops immunological therapies in patients with minimal residual disease, and for whom the mechanism of action of vaccines is ideally suited. The company was founded by Richard R. Lesniewski and Douglas G. McNeel in 2012 and is headquartered in Madison, WI. | Pharmaceuticals: Major | Director/Board Member | |
| THERAVANCE BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| SPERO THERAPEUTICS, INC. | Biotechnology | Founder | |
| NEXTCURE, INC. | Pharmaceuticals: Major | Founder | |
| KINIKSA PHARMACEUTICALS, LTD. | Pharmaceuticals: Major | Director/Board Member | |
| Pharmaceutical Research Institute | President | ||
Clear Creek Bio, Inc.
 Clear Creek Bio, Inc. Pharmaceuticals: MajorHealth Technology Clear Creek Bio, Inc. engages in the development of therapies that target nucleotide synthesis pathways. The firm focuses on the differentiation blockade in cancer and suppress replication of RNA-based viruses. It uses pharmacodynamic markers to ensure that each patient gets the right drug at the correct dose. The company was founded by David T. Scadden, David B. Sykes, Burt A. Adelman, and Vikram Sheel Kumar in 2017 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Investment Managers | Private Equity Investor | |
| Boston University School of Medicine | College/University | Corporate Officer/Principal | |
Avilar Therapeutics, Inc.
 Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Avilar Therapeutics is an American biopharmaceutical company that specializes in the discovery and development of extracellular protein degraders. The company is based in an undisclosed location. The company has developed a proprietary discovery platform that includes novel, high-affinity, small molecule asgpr ligands and advanced modeling of the biophysics, pharmacokinetics, and pharmacodynamics of atac mediated endocytosis and degradation. Avilar is developing atacs, a new class of protein degraders that shuttle disease-causing proteins from circulation to the endolysosome where the unwanted proteins are degraded. The company is leveraging their atac platform to create a broad and diverse pipeline of first-in-class extracellular protein degraders. The company was founded by Nathaniel Brooks Horwitz and Jamie Kasuboski. The CEO is Daniel S. Grau. | Miscellaneous Commercial Services | Chairman |
Statistik
International
| Vereinigte Staaten | 44 |
| Vereinigtes Königreich | 5 |
| Israel | 2 |
Sektoral
| Health Technology | 28 |
| Consumer Services | 13 |
| Finance | 6 |
| Commercial Services | 3 |
| Health Services | 2 |
Operativ
| Director/Board Member | 117 |
| Corporate Officer/Principal | 88 |
| Independent Dir/Board Member | 32 |
| Chief Tech/Sci/R&D Officer | 31 |
| Chairman | 28 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Arie Belldegrun | 42 |
| Samuel Saks | 28 |
| Russell Ellison | 20 |
| Peter S. Ringrose | 19 |
| Thomas Malley | 17 |
| Michael Richman | 16 |
| William F. Daly | 15 |
| Arturo Molina | 13 |
| Richard Benton Phillips | 13 |
| Perry B. Molinoff | 12 |
| Todd A. Verdoorn | 12 |
| Charles R. Eyler | 11 |
| Christopher Haqq | 10 |
| Milind Deshpande | 10 |
| Alan Auerbach | 9 |
- Börse
- Insiders
- Thomas W. Griffin
- Unternehmensverbindungen